National Institute of General Medical Sciences; Notice of Closed Meeting, 30080 [2015-12543]

Download as PDF 30080 Federal Register / Vol. 80, No. 100 / Tuesday, May 26, 2015 / Notices subsequent changes to the Web sites after this document publishes in the Federal Register.) Reis, H., and C. Judd, Handbook of Research Methods in Social and Personality Psychology, 2nd Ed. New York: Cambridge University Press (2014). Kerig, P.K., and D.H. Baucom, (Eds.). Couple Observational Coding Systems, Mahwah, NJ: Erlbaum (2004). Bakeman, R., Behavioral Observation and Coding, In H.T. Reis & C.M. Judd (Eds.) Handbook of Research Methods in Social and Personality Psychology,pp. 138–159. New York: Cambridge University Press (2000). Ewart, C.K., C.B. Taylor, H.C. Kraemer, and W.S. Agras. ‘‘High Blood Pressure and Marital Discord: Not Being Nasty Matters More Than Being Nice,’’ Health Psychology, 10, pp. 155–163 (1991). Spitzberg, B.H., and W.R. Cupach, Handbook of Interpersonal Competence Research, NY: Springer-Verlag (1989). Gottman, J.M., What Predicts Divorce? The Relationship Between Marital Processes and Marital Outcomes. Hillsdale, NJ: Erlbaum (1994). Rohrmann, B., ‘‘Risk Attitude Scales: Concepts, Questionnaires, Utilizations [Project Report],’’ University of Melbourne, Australia. Retrieved from https://www.rohrmannresearch.net/pdfs/ rohrmann-racreport.pdf (2005). Dated: May 18, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–12582 Filed 5–22–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Mandatory Guidelines for Federal Workplace Drug Testing Programs Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services. ACTION: HHS Approval of Entities That Certify Medical Review Officers (MRO). AGENCY: The current version of the Department of Health and Human Services (HHS) Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines), effective on October 1, 2010, addresses the role and qualifications of Medical Review Officers (MROs) and HHS approval of entities that certify MROs. Subpart M—Medical Review Officer (MRO), Section 13.1(b) of the Mandatory Guidelines, ‘‘Who may serve as an MRO?’’ states as follows: ‘‘Nationally recognized entities that certify MROs or subspecialty boards for physicians performing a review of Federal employee drug test results that seek approval by the Secretary must submit their qualifications and a sample mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:50 May 22, 2015 Jkt 235001 examination. Based on an annual objective review of the qualifications and content of the examination, the Secretary shall annually publish a list in the Federal Register of those entities and boards that have been approved.’’ HHS has completed its review of entities that certify MROs, in accordance with requests submitted by such entities to HHS. The HHS Secretary approves the following MRO certifying entities that offer MRO certification through examination: American Association of Medical Review Officers (AAMRO), P.O. Box 12873, Research Triangle Park, NC 27709; Phone: (800) 489–1839; Fax: (919) 490–1010; Email: cferrell@ aamro.com; Web site: https:// www.aamro.com/. Medical Review Officer Certification Council (MROCC), 836 Arlington Heights Road, #327, Elk Grove Village, IL 60007; Phone: (847) 631– 0599; Fax: (847) 483–1282; Email: mrocc@mrocc.org; Web site: https:// www.mrocc.org/. DATES: HHS approval is effective May 26, 2015. FOR FURTHER INFORMATION CONTACT: Jennifer Fan, Pharm.D., J.D., Division of Workplace Programs (DWP), Center for Substance Abuse Prevention (CSAP), Substance Abuse and Mental Health Services Administration (SAMHSA), 1 Choke Cherry Road, Room 7–1038, Rockville, MD 20857; Telephone: (240) 276–1759; Email: jennifer.fan@ samhsa.hhs.gov individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Initial Review Group; Training and Workforce Development Subcommittee—C. Date: June 8, 2015. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA 22314. Contact Person: Mona R. Trempe, Ph.D., Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3An.12A, Bethesda, MD 20892–4874, 301–594–3998, trempemo@ mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: May 19, 2015. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–12543 Filed 5–22–15; 8:45 am] BILLING CODE 4140–01–P Dated: May 15, 2015. Sylvia M. Burwell, Secretary. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2015–12559 Filed 5–22–15; 8:45 am] National Institutes of Health BILLING CODE 4160–20–P Prospective Grant of Exclusive License: Development of Autologous Tumor Infiltrating Lymphocyte Adoptive Cells for the Treatment of Lung, Breast, Bladder, and HPVPositive Cancers DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 AGENCY: National Institutes of Health, HHS. ACTION: Notice. This is notice, in accordance with 35 U.S.C. 209 and 37 CFR 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to the current licensee, Lion Biotechnologies, Inc., which is located in Woodland Hills, California to practice the inventions embodied in the following patent applications and applications claiming priority to these applications: SUMMARY: E:\FR\FM\26MYN1.SGM 26MYN1

Agencies

[Federal Register Volume 80, Number 100 (Tuesday, May 26, 2015)]
[Notices]
[Page 30080]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12543]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Initial Review Group; Training and Workforce Development 
Subcommittee--C.
    Date: June 8, 2015.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Monaco Alexandria, 480 King Street, Alexandria, VA 
22314.
    Contact Person: Mona R. Trempe, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 45 Center Drive, 
Room 3An.12A, Bethesda, MD 20892-4874, 301-594-3998, 
trempemo@mail.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives, National Institutes of Health, HHS)

    Dated: May 19, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-12543 Filed 5-22-15; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.